Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

cyclophosphamide/dactinomycin/doxorubicin/hydroxyurea/methotrexate/vincristine

Known as: CHAMOCA, CTX/DACT/DOX/HU/MTX/VCR 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
BACKGROUND Gestational trophoblastic disease (GTD) includes gestational trophoblastic tumour and hydatidiform mole. Many women of… Expand
Review
2006
Review
2006
BACKGROUND Gestational trophoblastic disease (GTD) includes gestational trophoblastic tumour and hydatidiform mole. Many women of… Expand
Highly Cited
1998
Highly Cited
1998
A retrospective and comparative study of high‐risk gestational trophoblastic tumor (GTT) treated with different chemoregimen from… Expand
1997
1997
Objective To define management options for women presenting with gestational trophoblastic disease (GTD) which had already… Expand
1997
1997
Gestational choriocarcinoma (CCA) is a well-defined tumor, but there may be a surprising variation in its morphologic appearance… Expand
1993
1993
A retrospective evaluation of prognostic factors in 55 patients suffering from metastatic gestational trophoblastic disease (MGTD… Expand
Highly Cited
1988
Highly Cited
1988
From June 1980 through December 1985, 36 high-risk GTT patients received Bagshawe's EMA/CO regimen, 22 as first-line, and 14 as… Expand
1987
1987
From January 1976 through December 1985, methotrexate (MTX) with citrovorum factor (CF) was administered as primary treatment to… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
1986
Highly Cited
1986
Summary. Identification of various prognostic factors at the start of chemotherapy allows patients with gestational trophoblastic… Expand
1986
1986
Nine patients with gestational trophoblastic disease resistant to multiagent chemotherapy, CHAMOCA, received methotrexate… Expand